CVS Health Inc. (NYSE:CVS) said it will not add Gilead Sciences Inc.’s (NASDAQ:GILD) new HIV prevention drug Yeztugo to its commercial plans. In June, the U.S. Food and Drug Administration (FDA) ...
Zacks Investment Research on MSN
CVS Health Posts Strong Q3 Earnings: How to Play the Stock Now?
CVS Health CVS continues to enjoy the strength of its diversified businesses. Third-quarter 2025 revenues hit a record $103 billion, up 8% year over year, with all segments contributing to growth. The ...
The largest contract paid CVS $200 million from 2020 through 2023, the period when McKee became governor and first campaigned against Foulkes.
Eli Lilly (LLY) is exiting CVS Health’s (CVS) drug benefit plan for its employees after the managed care giant decided to ...
That said, CVS continues to maintain a prudent outlook for possible changes in the vaccine market demand and a softening consumer environment. The Zacks Consensus Estimate for CVS’ Pharmacy & Consumer ...
Retailers’ grand plans to enter the primary care market have so far been unsuccessful. But CVS Health believes it can succeed where others have stumbled – and Houston is serving as a testing ground.
We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best health ...
They have the responsibility to be a fair partner to Connecticut families. Instead, they continue to put profits before ...
Trividia Health, Inc., announced today that it's TRUE METRIX (R) Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...
CVS Caremark commercial members receive access to accurate and confident blood glucose testing Trividia Health, Inc., announced today that it’s TRUE METRIX® Self-Monitoring Blood Glucose Systems are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results